Filing Details

Accession Number:
0001209191-15-026215
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-13 18:25:13
Reporting Period:
2015-03-11
Filing Date:
2015-03-13
Accepted Time:
2015-03-13 18:25:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949699 Pharmacyclics Inc PCYC Pharmaceutical Preparations (2834) 943148201
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569769 Singh Manmeet Soni C/O Pharmacyclics, Inc.
995 East Arques Ave
Sunnyvale CA 94085
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-11 7,848 $61.60 65,875 No 4 M Direct
Common Stock Acquisiton 2015-03-11 5,000 $106.75 70,875 No 4 M Direct
Common Stock Acquisiton 2015-03-11 11,250 $70.37 82,125 No 4 M Direct
Common Stock Disposition 2015-03-11 24,098 $254.15 58,027 No 4 S Direct
Common Stock Disposition 2015-03-13 902 $254.88 57,125 No 4 S Direct
Common Stock Disposition 2015-03-13 2,514 $254.91 54,611 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-03-11 7,848 $0.00 7,848 $61.60
Common Stock Stock Option (Right to Buy) Disposition 2015-03-11 5,000 $0.00 5,000 $106.75
Common Stock Stock Option (Right to Buy) Disposition 2015-03-11 11,250 $0.00 11,250 $70.37
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,152 2012-10-26 2022-10-26 No 4 M Direct
15,000 2013-08-16 2023-08-16 No 4 M Direct
18,750 2013-02-12 2023-02-12 No 4 M Direct
Footnotes
  1. The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on September 6, 2013 and 1/36th of the remaining shares will vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on September 6, 2016, subject to the Reporting Person's continued employment or service relationship with the Issuer on each of the vesting dates.
  2. The option vests 12/48ths shall vest on each of August 16, 2014, August 16, 2015 and August 16, 2016 and August 16,2017. The vesting of the options is subject to satisfaction of certain performance criteria.
  3. The option vests 3/48 on April 11, 2013; the remainder vests proportionately on each of April 11, 2014, April 11, 2015 and April 11, 2016, subject to satisfaction of certain performance criteria with respect to each such period.